Article
Oncology
Seri Hong, Young-Joo Won, Jae Jun, Kyu-Won Jung, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan
Summary: The study presents national cancer statistics and trends in Korea for 2018, covering incidence, mortality, survival, and prevalence rates. Overall, cancer incidence rates increased annually by 3.3% from 1999 to 2012, then decreased by 5.4% annually from 2012 to 2015, followed by insignificant changes. Meanwhile, cancer mortality rates have been decreasing since 2002, with a more rapid decline in recent years.
CANCER RESEARCH AND TREATMENT
(2021)
Article
Oncology
Mee Joo Kang, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
Summary: This study provides national cancer statistics and trends in Korea for 2019, including incidence, mortality, survival, and prevalence rates. The incidence of lung cancer has surpassed thyroid cancer to become the most frequent cancer in Korea. Overall cancer incidence rates increased from 1999 to 2012, then decreased from 2012 to 2015, followed by no significant changes. The incidence of thyroid cancer started increasing again from 2016. Cancer mortality rates have been decreasing since 2002, with a more rapid decline in recent years. The 5-year relative survival rate between 2015 and 2019 was 70.7%, leading to over 2 million prevalent cases in 2019.
CANCER RESEARCH AND TREATMENT
(2022)
Article
Oncology
Yao Xu, Fanqi Shi, Yanting Zhang, Mengfan Yin, Xiuxin Han, Jinyan Feng, Guowen Wang
Summary: This study aimed to update the recent epidemiologic estimates of malignant bone tumors. The results showed differences in incidence and mortality rates across tumor types and demographic variables, providing potential suggestions for further adjustment of medical resources.
INTERNATIONAL JOURNAL OF CANCER
(2023)
Article
Oncology
Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E. Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
Summary: This study aimed to estimate Korea's current cancer burden by reporting the projected cancer incidence and mortality for the year 2023. Cancer incidence and mortality were projected using a linear regression model and population data. It is estimated that there will be 273,076 new cancer cases and 81,818 cancer deaths in Korea in 2023. Lung cancer is expected to be the most common cancer site, followed by thyroid, breast, colon and rectum, and stomach cancers. The incidence rates for all types of cancer are estimated to gradually decrease in Korea. These estimates provide important information for planning and evaluating cancer control programs.
CANCER RESEARCH AND TREATMENT
(2023)
Article
Oncology
Kyu-Won Jung, Young-Joo Won, Mee Joo Kang, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
Summary: This study estimated the projected cancer incidence and mortality for the year 2022 in Korea. By using cancer incidence and mortality data from national databases, linear regression models were fitted to project the rates for different types of cancer. It is projected that there will be approximately 274,488 new cancer cases and 81,277 cancer deaths in Korea in 2022. Thyroid cancer is expected to be the most common cancer site, followed by lung, colon and rectal, breast, and stomach cancers. Lung cancer is the most common type leading to death.
CANCER RESEARCH AND TREATMENT
(2022)
Article
Oncology
Kyu-Won Jung, Young-Joo Won, Seri Hong, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
Summary: It is projected that in 2021, there will be 259,999 new cases of cancer and 81,567 cancer deaths in Korea. Lung cancer is expected to be the most common cancer site, followed by thyroid, colon and rectum, breast, and stomach cancers. These five cancers are predicted to represent half of Korea's overall cancer burden.
CANCER RESEARCH AND TREATMENT
(2021)
Article
Oncology
Cham Thi Nguyen, Insang Song, Inkyung Jung, Yoon-Jung Choi, Sun-Young Kim
Summary: This study investigated the changes in spatial clusters of cancer incidence and mortality by major cancer types in South Korea from 1999 through 2013. The findings showed that the incidence clusters for lung, stomach, and liver cancer remained stable over 15 years, while mortality clusters were relocated to similar areas as the incidence clusters. On the other hand, colorectal, breast, cervical, and prostate cancer displayed consistently different cluster locations over time, indicating the disappearance of existing clusters and the appearance of new clusters. Cluster areas tended to have higher proportions of older population, unemployment, smoking, and cancer screening compared to non-cluster areas.
Article
Oncology
Meerim Park, Jiwon Lim, Jun Ah Lee, Byung Kiu Park, Kyu-Won Jung, Young-Joo Won, Hyeon Jin Park
Summary: This study investigated the incidence and relative survival rates for cancers among adolescents and young adults aged 15-39 in Korea between 1993 and 2016. The ASR of all cancers among AYAs was 654.5 per million, with carcinoma being the most diagnosed type. Thyroid carcinoma and non-Hodgkin lymphoma showed the most rapid increase in incidence. The 5-year RSR among AYAs significantly improved from 62.1% to 90.8%, with the most marked survival improvement found for leukemia and lymphoma. Further research focusing on cancer epidemiology and therapeutic strategies for AYAs is needed.
CANCER RESEARCH AND TREATMENT
(2021)
Review
Public, Environmental & Occupational Health
Rock Bum Kim, Jang-Rak Kim, Jin Yong Hwang
Summary: This review provides a comprehensive analysis of the epidemiological indicators of myocardial infarction in Korea, comparing them with other high-income countries. The results indicate that although there is an increasing trend, the hospitalization incidence, prevalence, and mortality rate of myocardial infarction are lower in Korea than in other countries. The study emphasizes the need for comprehensive national-level support and surveillance systems to collect accurate epidemiological indicators.
EPIDEMIOLOGY AND HEALTH
(2022)
Article
Psychiatry
Siiri-Liisi Kraav, Soili M. Lehto, Jussi Kauhanen, Sari Hantunen, Tommi Tolmunen
Summary: Loneliness and social isolation are associated with cancer incidence, even after adjusting for health-related factors. However, social isolation does not have a significant connection to specific types of cancer, while loneliness is linked to lung cancer incidence.
PSYCHIATRY RESEARCH
(2021)
Article
Oncology
Dong Hoon Suh, Hyeong In Ha, Yeon Jee Lee, Jiwon Lim, Young-Joo Won, Myong Cheol Lim
Summary: This study aimed to investigate the trends of uterine cervical cancer incidence and survival outcomes from 1999 to 2018. The results showed a decrease in the absolute incidence of cervical cancer, with a significant decline in squamous cell carcinoma and a slow increase in adenocarcinoma. Adenocarcinoma was diagnosed at a younger age but had worse survival outcomes compared to squamous cell carcinoma. Early-stage disease and younger age were associated with better survival rates.
JOURNAL OF GYNECOLOGIC ONCOLOGY
(2023)
Article
Gastroenterology & Hepatology
Bo Hyun Kim, Dahhay Lee, Kyu-Won Jung, Young-Joo Won, Hyunsoon Cho
Summary: This study found that patients with liver cancer are most likely to die from liver cancer and related liver disease, even 10 years after the diagnosis. Specialized long-term follow-up care is needed.
CLINICAL AND MOLECULAR HEPATOLOGY
(2022)
Article
Public, Environmental & Occupational Health
Tomas Tanskanen, Karri J. M. Seppa, Anni Virtanen, Nea K. Malila, Janne M. Pitkaniemi
Summary: The increasing cancer burden in the oldest old poses a major challenge for health care in Finland, with nearly 1 in 10 cancers diagnosed in individuals aged 85 and above. Excess cancer mortality can be proposed as a measure of cancer-related mortality in older populations with competing risks of death.
AMERICAN JOURNAL OF EPIDEMIOLOGY
(2021)
Article
Oncology
Chang-Mo Oh, Jiwon Lim, Yuh Seog Jung, Yeol Kim, Kyu-Won Jung, Seri Hong, Young-Joo Won
Summary: The study examined the trends of thyroid cancer incidence in South Korea and found that the incidence began to decline in 2012. Meanwhile, the mortality rate and incidence of distant cancer related to thyroid cancer were also decreasing gradually.
Article
Cardiac & Cardiovascular Systems
Lars Joran Kjerpeseth, Jannicke Igland, Randi Selmer, Hanne Ellekjaer, Arnljot Tveit, Trygve Berge, Silje Madeleine Kalsto, Ingrid Elisabeth Christophersen, Marius Myrstad, Eva Skovlund, Grace Margrethe Egeland, Grethe Seppola Tell, Inger Ariansen
Summary: The overall incidence rates of atrial fibrillation in the adult Norwegian population remained stable from 2004 to 2014, with the exception of a yearly increase in the 18-44 age group. The prevalence of atrial fibrillation at the end of 2014 was 3.4% in the adult population. Signs of increasing incidence of early-onset atrial fibrillation (<45 years) are concerning and require further investigation.
Article
Gastroenterology & Hepatology
Mee Joo Kang, Jiwon Lim, Sung-Sik Han, Hyeong Min Park, Sun-Whe Kim, Young-Joo Won, Sang-Jae Park
Summary: Misclassification of Klatskin tumors can lead to overestimation of intrahepatic bile duct cancer (iBDC) and underestimation of extrahepatic bile duct cancer (eBDC) incidences in Korea, affecting the highly endemic rates of bile duct cancer in the country.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
(2021)
Article
Gastroenterology & Hepatology
Hyeong M. Park, Hye Y. Jang, Dong E. Lee, Mee J. Kang, Sung-Sik Han, Sun-Whe Kim, Sang-Jae Park
Summary: This study investigated the vascularity of intrahepatic cholangiocarcinoma (ICC) on computed tomography (CT) images and its association with ICC recurrence after surgery and prognosis after recurrence. The study found that hypervascular ICC was associated with longer recurrence-free survival and better survival after recurrence.
Article
Oncology
Mee Joo Kang, Jiwon Lim, Sung-Sik Han, Hyeong Min Park, Sang-Jae Park, Young-Joo Won, Sun-Whe Kim
Summary: This study investigated the trends in initial treatment and corresponding prognosis of patients with exocrine pancreatic cancer (EPC) in Korea. The findings showed that less than half of the patients with localized EPC underwent surgical treatment, and this proportion decreased significantly in elderly patients. Surgical treatment led to higher 5-year relative survival rates compared to no active treatment for localized EPC. Therefore, clinicians should pay attention to elderly patients with EPC and provide appropriate medical advice.
CANCER RESEARCH AND TREATMENT
(2022)
Review
Gastroenterology & Hepatology
Mee Joo Kang, Sun-Whe Kim
Summary: Pancreatic cancer surgery is challenging due to high operative morbidity rate, unsatisfactory survival outcomes, and difficulties in obtaining high-level evidence. Surgical doubts arise as even after curative surgery, survival outcomes are poor. Conducting clinical trials in pancreatic surgery field is difficult and skepticism about their quality impacts their impact on clinical practice.
ANNALS OF GASTROENTEROLOGICAL SURGERY
(2021)
Article
Oncology
Mee Joo Kang, Eun-Seung Yu, Young Hwa Kang, Hyeong Min Park, Sang-Jae Park, Sun-Whe Kim, Jong-Heun Kim, Sung-Sik Han
Summary: This study investigated the prevalence of psychological symptoms in patients undergoing pancreatoduodenectomy and evaluated the effectiveness of a distress management protocol. The results showed that over one-third of the patients experienced psychological symptoms before and after the surgery, but less than 45% of them expressed their need for psychological support. Implementing routine screening and referral protocols improved surgeons' responsiveness to patients' psychological symptoms.
CANCER RESEARCH AND TREATMENT
(2022)
Article
Surgery
Jangho Park, Sung-Sik Han, Sang-Jae Park, Mee Joo Kang, Hyeong Min Park, Jihye Yu, Sun-Whe Kim
Summary: This study compared the morbidity following pancreaticoduodenectomy (PD) between a fluid restriction group and a conventional management group. The results showed that fluid restriction did not decrease the incidence of complications, including postoperative pancreatic fistula (POPF). It also did not decrease urine output or increase the incidence of acute kidney injury (AKI).
ANZ JOURNAL OF SURGERY
(2022)
Article
Oncology
Kyu-Won Jung, Young-Joo Won, Mee Joo Kang, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
Summary: This study estimated the projected cancer incidence and mortality for the year 2022 in Korea. By using cancer incidence and mortality data from national databases, linear regression models were fitted to project the rates for different types of cancer. It is projected that there will be approximately 274,488 new cancer cases and 81,277 cancer deaths in Korea in 2022. Thyroid cancer is expected to be the most common cancer site, followed by lung, colon and rectal, breast, and stomach cancers. Lung cancer is the most common type leading to death.
CANCER RESEARCH AND TREATMENT
(2022)
Article
Oncology
Mee Joo Kang, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
Summary: This study provides national cancer statistics and trends in Korea for 2019, including incidence, mortality, survival, and prevalence rates. The incidence of lung cancer has surpassed thyroid cancer to become the most frequent cancer in Korea. Overall cancer incidence rates increased from 1999 to 2012, then decreased from 2012 to 2015, followed by no significant changes. The incidence of thyroid cancer started increasing again from 2016. Cancer mortality rates have been decreasing since 2002, with a more rapid decline in recent years. The 5-year relative survival rate between 2015 and 2019 was 70.7%, leading to over 2 million prevalent cases in 2019.
CANCER RESEARCH AND TREATMENT
(2022)
Article
Oncology
Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E. Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
Summary: This study aimed to estimate Korea's current cancer burden by reporting the projected cancer incidence and mortality for the year 2023. Cancer incidence and mortality were projected using a linear regression model and population data. It is estimated that there will be 273,076 new cancer cases and 81,818 cancer deaths in Korea in 2023. Lung cancer is expected to be the most common cancer site, followed by thyroid, breast, colon and rectum, and stomach cancers. The incidence rates for all types of cancer are estimated to gradually decrease in Korea. These estimates provide important information for planning and evaluating cancer control programs.
CANCER RESEARCH AND TREATMENT
(2023)
Article
Oncology
Sin Hye Park, Mee Joo Kang, E. Hwa Yun, Kyu-Won Jung
Summary: This study investigated the trends of gastric cancer in Korea and found a decrease in the incidence and mortality rates, as well as changes in tumor stage and treatment methods. Over the past 20 years, the situation of gastric cancer in Korea has changed, and these findings provide important information for understanding the current status of gastric cancer.
JOURNAL OF GASTRIC CANCER
(2022)
Article
Medicine, General & Internal
Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han
Summary: Based on the cancer registry data in Korea, this study analyzed the epidemiologic features of hepatobiliary and pancreatic cancers and predicted the future incidence and mortality rates. The study found that the annual incidence and mortality cases of these cancers are generally increasing, with pancreatic cancer being the leading cause of death.
JOURNAL OF KOREAN MEDICAL SCIENCE
(2022)
Article
Multidisciplinary Sciences
Mee Joo Kang, Jiwon Lim, Sung-Sik Han, Hyeong Min Park, Sun-Whe Kim, Woo Jin Lee, Sang Myung Woo, Tae Hyun Kim, Young-Joo Won, Sang-Jae Park
Summary: This study retrospectively reviewed the treatment pattern and prognosis of biliary tract cancer (BTC) according to tumor location. The results showed that tumor location has an impact on treatment pattern and prognosis. Vater's ampulla cancer was the most common tumor location for BTC patients, followed by extrahepatic bile duct cancer, gallbladder cancer, and intrahepatic bile duct cancer. The highest rate of no active anti-cancer treatment was found in intrahepatic bile duct cancer, while the highest 5-year relative survival rate was found in Vater's ampulla cancer. Older patients had a higher risk of receiving no active anti-cancer treatment in each tumor location.
SCIENTIFIC REPORTS
(2022)
Article
Education & Educational Research
Mee Joo Kang, Reuben Kwesi Sakyi Ngissah
BMC MEDICAL EDUCATION
(2020)
Article
Public, Environmental & Occupational Health
Mee Joo Kang, Kwabena Breku Apea-Kubi, Kojo Assoku Kwarko Apea-Kubi, Nyabenda-Gomwa Adoula, James Nii Noi Odonkor, Alfred Korbia Ogoe
ANNALS OF GLOBAL HEALTH
(2020)
